Skip to main content
Erschienen in: Breast Cancer Research 3/2011

01.06.2011 | Viewpoint

Waking up dormant tumors

verfasst von: Joyce C Tse, Raghu Kalluri

Erschienen in: Breast Cancer Research | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

As appreciation grows for the contribution of the tumor microenvironment to the progression of cancer, new evidence accumulates to support that the participation of stromal cells can extend beyond the local environment. Recently, Elkabets and colleagues demonstrated a systemic interaction between cancer cells and distant bone marrow cells to support the growth of otherwise indolent tumor cells at a secondary site, raising thought-provoking questions regarding the involvement of stromal cells in maintaining metastatic dormancy.
Literatur
1.
Zurück zum Zitat Wels J, Kaplan RN, Rafii S, Lyden D: Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 2008, 22: 559-574. 10.1101/gad.1636908.CrossRefPubMedPubMedCentral Wels J, Kaplan RN, Rafii S, Lyden D: Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 2008, 22: 559-574. 10.1101/gad.1636908.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Joyce JA: Therapeutic targeting of the tumor microenvironment. Cancer Cell. 2005, 7: 513-520. 10.1016/j.ccr.2005.05.024.CrossRefPubMed Joyce JA: Therapeutic targeting of the tumor microenvironment. Cancer Cell. 2005, 7: 513-520. 10.1016/j.ccr.2005.05.024.CrossRefPubMed
3.
Zurück zum Zitat McAllister SS, Weinberg RA: Tumor-host interactions: a far-reaching relationship. J Clin Oncol. 2010, 28: 4022-4028. 10.1200/JCO.2010.28.4257.CrossRefPubMed McAllister SS, Weinberg RA: Tumor-host interactions: a far-reaching relationship. J Clin Oncol. 2010, 28: 4022-4028. 10.1200/JCO.2010.28.4257.CrossRefPubMed
4.
Zurück zum Zitat McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, Reinhardt F, Harris LN, Hylander BL, Repasky EA, Weinberg RA: Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell. 2008, 133: 994-1005. 10.1016/j.cell.2008.04.045.CrossRefPubMedPubMedCentral McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, Reinhardt F, Harris LN, Hylander BL, Repasky EA, Weinberg RA: Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell. 2008, 133: 994-1005. 10.1016/j.cell.2008.04.045.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirström K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS: Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest. 121: 784-799. Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirström K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS: Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest. 121: 784-799.
6.
Zurück zum Zitat Ong CH, Bateman A: Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol. 2003, 18: 1275-1288.PubMed Ong CH, Bateman A: Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol. 2003, 18: 1275-1288.PubMed
7.
Zurück zum Zitat Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, Fan ST: Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology. 2008, 47: 1524-1532. 10.1002/hep.22191.CrossRefPubMed Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, Fan ST: Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology. 2008, 47: 1524-1532. 10.1002/hep.22191.CrossRefPubMed
Metadaten
Titel
Waking up dormant tumors
verfasst von
Joyce C Tse
Raghu Kalluri
Publikationsdatum
01.06.2011
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 3/2011
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2872

Weitere Artikel der Ausgabe 3/2011

Breast Cancer Research 3/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.